检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:尤晓光[1] 彭明丽[2] 江少凡[1,3] 陈贤飞[1] 涂蓉[1]
机构地区:[1]海南医学院附属医院放射科,海口570102 [2]西北大学,710127 [3]遵义医学院附属医院,560001
出 处:《放射学实践》2014年第10期1147-1150,共4页Radiologic Practice
基 金:国家自然基金课题(81160177);海南省自然基金(811212);海南医学院科研培育基金(HY2010-017)
摘 要:目的:探讨荧光VEGF165-USPIO(血管内皮生长因子165-超顺磁性氧化铁)作为MR对比剂的可行性,检测该对比剂体外对VEGF165抗原的靶向性。方法:通过氨基-羧基偶联方式将VEGF165单克隆抗体和USPIO连接,然后将Cy5.5标记到单克隆抗体表面,构建Cy5.5-anti-VEGF165-USPIO靶向对比剂。以离心和磁分离器的洗涤手段进行改良ELISA实验检测其体外活性,实验组加入0.25ml的荧光-anti-VEGF165-USPIO,对照组加入相同量的荧光USPIO,每组各设5个离心管,两样本为计量资料,采用独立t检验比较不同组间吸光值差异有无显著性。结果:通过分光光度计验证对比剂连接成功,VEGF165单克隆抗体偶联率达到了71.7%,CY5.5的偶联率为83.3%。ELISA实验表明实验组和对照组各自吸光值差异有显著性意义(P<0.05),实验组OD(吸光值)明显高于对照组。结论:荧光anti-VEGF165-USPIO体外有结合VEGF165的活性,为进一步的MR肿瘤靶向对比剂研究奠定了实验基础。Objective:To explore the feasibility of the synthesis of a MR contrast agent Fluorescence VEGF165-US-PIO and to establish an ELISA method for detecting the targeting of this agent to VEGF165-USPIO antigen in vitro. Methods:By applying the coupling of amino-carboxyl,the VEGF165 monoclonal antibody and USPIO were coupled.Then the Cy5.5 was marked to the surfac of monoclonal antibody,and Cy5.5 anti-VEGF165-USPIO targeting contrast agent was established.The centrifuge and magnetic separation were used as the washing solution.Two groups were set up.In the test group,fluorescence anti-VEGF165-USPIO (0.25mL)was used,while in the control group the same amount of fluorescence-USPIO was applied.Each group had five centrifugal pipes.By applying the two-sample independent T-test,we compared the data obtained from both washings.Results:The new type of magnetic resonance contrast agent was successfully combined. Coupling efficiency of VEGF165 monoclonal antibody was 71.7%,and CY5.5 was 83.3%.ELISA assay showed that ab-sorbance values of the test group and the control group were different (P 〈0.05 ),while the test group (absorbance) showing a significantly higher OD (absorbance ).Conclusion:Fluorescent anti-VEGF165-USPIO has activity to bind VEGF165 in vitro.
分 类 号:R445.2[医药卫生—影像医学与核医学] R341[医药卫生—诊断学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.119.131.131